Rockwell Medical will Present Data on Triferic Intravenous (IV) Administration at the 19th International Conference on Dialysis ...
WIXOM, Mich., Jan. 26, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for the treatment of iron …